These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


356 related items for PubMed ID: 10235259

  • 1. The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis.
    Imai Y, Kimura T, Murakami A, Yajima N, Sakamaki K, Yonehara S.
    Nature; 1999 Apr 29; 398(6730):777-85. PubMed ID: 10235259
    [Abstract] [Full Text] [Related]

  • 2. The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis.
    Chen CY, Juo P, Liou JS, Li CQ, Yu Q, Blenis J, Faller DV.
    Cell Growth Differ; 2001 Jun 29; 12(6):297-306. PubMed ID: 11432804
    [Abstract] [Full Text] [Related]

  • 3. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex.
    Rasper DM, Vaillancourt JP, Hadano S, Houtzager VM, Seiden I, Keen SL, Tawa P, Xanthoudakis S, Nasir J, Martindale D, Koop BF, Peterson EP, Thornberry NA, Huang J, MacPherson DP, Black SC, Hornung F, Lenardo MJ, Hayden MR, Roy S, Nicholson DW.
    Cell Death Differ; 1998 Apr 29; 5(4):271-88. PubMed ID: 10200473
    [Abstract] [Full Text] [Related]

  • 4. A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis.
    Yamamoto M, Torigoe T, Kamiguchi K, Hirohashi Y, Nakanishi K, Nabeta C, Asanuma H, Tsuruma T, Sato T, Hata F, Ohmura T, Yamaguchi K, Kurotaki T, Hirata K, Sato N.
    Cancer Res; 2005 Oct 01; 65(19):8706-14. PubMed ID: 16204039
    [Abstract] [Full Text] [Related]

  • 5. Actinomycin D-mediated sensitization of AIDS-Kaposi's sarcoma cells to Fas-mediated apoptosis: involvement of the mitochondrion-dependent pathway.
    Mori S, Murakami-Mori K, Nakamura S, Bonavida B.
    Int J Oncol; 2002 Apr 01; 20(4):819-26. PubMed ID: 11894131
    [Abstract] [Full Text] [Related]

  • 6. Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells.
    You KR, Shin MN, Park RK, Lee SO, Kim DG.
    Hepatology; 2001 Dec 01; 34(6):1119-27. PubMed ID: 11732001
    [Abstract] [Full Text] [Related]

  • 7. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis.
    Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Dröge W, Krammer PH, Fiers W, Schulze-Osthoff K.
    Nature; 1995 May 04; 375(6526):81-3. PubMed ID: 7536901
    [Abstract] [Full Text] [Related]

  • 8. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
    Gil J, Esteban M.
    Oncogene; 2000 Jul 27; 19(32):3665-74. PubMed ID: 10951573
    [Abstract] [Full Text] [Related]

  • 9. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S, Meyer E, Debatin KM.
    Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673
    [Abstract] [Full Text] [Related]

  • 10. Selective up-regulation of phosphatidylinositol 3'-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis.
    Varadhachary AS, Peter ME, Perdow SN, Krammer PH, Salgame P.
    J Immunol; 1999 Nov 01; 163(9):4772-9. PubMed ID: 10528176
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide inhibits APO-1/Fas-mediated cell death.
    Dimmeler S, Haendeler J, Sause A, Zeiher AM.
    Cell Growth Differ; 1998 May 01; 9(5):415-22. PubMed ID: 9607562
    [Abstract] [Full Text] [Related]

  • 12. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM.
    Oncogene; 2001 Mar 01; 20(9):1063-75. PubMed ID: 11314043
    [Abstract] [Full Text] [Related]

  • 13. Molluscum contagiosum virus inhibitors of apoptosis: The MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein.
    Shisler JL, Moss B.
    Virology; 2001 Mar 30; 282(1):14-25. PubMed ID: 11259186
    [Abstract] [Full Text] [Related]

  • 14. The death effector domain protein family: regulators of cellular homeostasis.
    Tibbetts MD, Zheng L, Lenardo MJ.
    Nat Immunol; 2003 May 30; 4(5):404-9. PubMed ID: 12719729
    [Abstract] [Full Text] [Related]

  • 15. Suppression of receptor-mediated apoptosis by death effecter domain recruiting domain binding peptide aptamer.
    Kim GS, Park YA, Choi YS, Choi YH, Choi HW, Jung YK, Jeong S.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1165-70. PubMed ID: 16581027
    [Abstract] [Full Text] [Related]

  • 16. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 May 19; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 17. P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation.
    Ruefli AA, Tainton KM, Darcy PK, Smyth MJ, Johnstone RW.
    Cell Death Differ; 2002 Nov 19; 9(11):1266-72. PubMed ID: 12404126
    [Abstract] [Full Text] [Related]

  • 18. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A, Lam A, Datta R, Srivastava RK.
    Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196
    [Abstract] [Full Text] [Related]

  • 19. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain.
    Eberstadt M, Huang B, Chen Z, Meadows RP, Ng SC, Zheng L, Lenardo MJ, Fesik SW.
    Nature; 1998 Apr 30; 392(6679):941-5. PubMed ID: 9582077
    [Abstract] [Full Text] [Related]

  • 20. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A, Liebermann DA, Hoffman B.
    Oncogene; 2002 Feb 28; 21(10):1600-10. PubMed ID: 11896589
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.